Search

Search Constraints

You searched for: Author/Creator Pohlmann, Alessandra

Search Results

1. Circulating CXCL10 in cirrhotic portal hypertension might reflect systemic inflammation and predict ACLF and mortality. (6th November 2017)

2. Circulating microbiome in blood of different circulatory compartments. Issue 3 (26th March 2018)

3. Fat‐free muscle mass in magnetic resonance imaging predicts acute‐on‐chronic liver failure and survival in decompensated cirrhosis. Issue 3 (24th January 2018)

4. Fibroblast growth factor 21 is an early predictor of acute‐on‐chronic liver failure in critically ill patients with cirrhosis. Issue 5 (6th April 2018)

5. Fibroblast growth factor 21 is independently associated with severe hepatic steatosis in non‐obese HIV‐infected patients. (5th April 2019)

6. Increase in liver stiffness after transjugular intrahepatic portosystemic shunt is associated with inflammation and predicts mortality. Issue 4 (20th February 2018)

7. Increased myocardial contractility identifies patients with decompensated cirrhosis requiring liver transplantation. Issue 1 (1st December 2017)

8. MicroRNA‐200a: A stage‐dependent biomarker and predictor of steatosis and liver cell injury in human immunodeficiency virus patients. Issue 1 (February 2017)

9. Sarcopenia Is Associated With Development of Acute-on-Chronic Liver Failure in Decompensated Liver Cirrhosis Receiving Transjugular Intrahepatic Portosystemic Shunt. Issue 4 (April 2019)

10. Significant reduction in heart rate variability is a feature of acute decompensation of cirrhosis and predicts 90‐day mortality. Issue 5 (8th July 2019)